Cargando…
Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice
Coronavirus disease 19 (COVID-19) is the clinical manifestation of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection. A hallmark of COVID-19 is a lung inflammation characterized by an abundant leukocyte infiltrate, elevated levels of cytokines/chemokines, lipid mediators of infl...
Autores principales: | Dubuc, Isabelle, Prunier, Julien, Lacasse, Émile, Gravel, Annie, Puhm, Florian, Allaeys, Isabelle, Archambault, Anne-Sophie, Gudimard, Leslie, Villano, Rosaria, Droit, Arnaud, Flamand, Nicolas, Boilard, Éric, Flamand, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264370/ https://www.ncbi.nlm.nih.gov/pubmed/35812400 http://dx.doi.org/10.3389/fimmu.2022.893792 |
Ejemplares similares
-
SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB
por: Lacasse, Émile, et al.
Publicado: (2023) -
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells
por: Puhm, Florian, et al.
Publicado: (2022) -
Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
por: Zaid, Younes, et al.
Publicado: (2021) -
Mapping the Human Herpesvirus 6B Transcriptome
por: Gravel, Annie, et al.
Publicado: (2021) -
Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis
por: Laroche, Audree, et al.
Publicado: (2022)